Author:
Peet M.,Bethell M. S.,Coates A.,Khamnee A. K.,Hall P.,Cooper S. J.,King D. J.,Yates R. A.
Abstract
SummaryFifty-three hospitalized chronic schizophrenic patients were treated with either propranolol, chlorpromazine or placebo in a double-blind randomized trial for up to three months. Propranolol in a usual dose of 640 mg/day, produced marked cardiovascular effects but no improvement in schizophrenic symptomatology relative to placebo. The effects of chlorpromazine were small and inconsistent.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Is elevated norepinephrine an etiological factor in some cases of schizophrenia?;Psychiatry Research;2014-03
2. Chlorpromazine versus placebo for schizophrenia;Cochrane Database of Systematic Reviews;2014-01-06
3. Chlorpromazine versus placebo for schizophrenia;Cochrane Database of Systematic Reviews;2007-04-18
4. Alternatives to Placebo-Controlled Trials;Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques;2007-03
5. Chlorpromazine versus placebo for schizophrenia;Cochrane Database of Systematic Reviews;2003-04-22